China Universal Asset Management Company’s Eledon Pharmaceuticals ELDN Stock Holding History

China Universal Asset Management Company’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63K	Buy	+16,000	New	+$58.2K	﹤0.01%	448

Other funds holding ELDN

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return

Baker Ellis Asset Management Vancouver, Washington $964M AUM 39.24% 1-Year Est. Return

Revolve Wealth Partners Hackensack, New Jersey $965M AUM 22.88% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

GK Wealth Management Reno, Nevada $190M AUM 66.42% 1-Year Est. Return

China Universal Asset Management Company's ELDN Position: Q2 2026 in Review

China Universal Asset Management Company opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 16,000 shares worth $63K. The stake represents ﹤0.01% of the portfolio and ranks #448 among its holdings.

28 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

China Universal Asset Management Company held 16,000 shares of Eledon Pharmaceuticals worth $63K as of Q2 2026.
Eledon Pharmaceuticals was a new China Universal Asset Management Company position in Q2 2026.
Eledon Pharmaceuticals made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #448 holding.
28 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.